Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Zou

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Zhonghua Yi Xue Za Zhi|March 5, 2019
[The correlation between findings of whole-body diffusion weighted imaging and clinical result in patients with multiple myeloma]W Y Huang, M Yang, W W Sui, et al.
Fa Yi Xue Za Zhi|February 7, 2021
[Research Status of Postmortem MSCT Angiography in Forensic Science]L Wan, D H Zou, M W Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 23, 2018
[Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation]W Y Huang, D H Zou, W Liu, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|March 28, 2024
[Strolling through the glorious years of Alveolar Surgery, bravely stepping onto the path of practice and innovation]Y M Wang, Y Xue, J H Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]Y Yu, W J Xiong, J W Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 15, 2022
[Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]Y Yu, Q Sun, C W Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 7, 2023
[A prospective clinical trial of TCD-induced regimen for symptomatic Waldenström macroglobulinemia]Y S Huang, W J Xiong, Y Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Dose-adjusted EPOCH/EDOCH plus rituximab in untreated double-protein expression lymphoma]W Liu, J Li, W Y Huang, et al.
Fa Yi Xue Za Zhi|January 24, 2020
Research Progress on Postmortem Changes of Computed Tomography Imaging Characteristics on CorpsesH W Dong, Y Sun, H Qian, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 22, 2020
[The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion]R Lyu, Y T Yan, S H Yi, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Zhonghua Yi Xue Za Zhi|March 5, 2019
[The correlation between findings of whole-body diffusion weighted imaging and clinical result in patients with multiple myeloma]W Y Huang, M Yang, W W Sui, et al.
Fa Yi Xue Za Zhi|February 7, 2021
[Research Status of Postmortem MSCT Angiography in Forensic Science]L Wan, D H Zou, M W Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 23, 2018
[Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation]W Y Huang, D H Zou, W Liu, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|March 28, 2024
[Strolling through the glorious years of Alveolar Surgery, bravely stepping onto the path of practice and innovation]Y M Wang, Y Xue, J H Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]Y Yu, W J Xiong, J W Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 15, 2022
[Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]Y Yu, Q Sun, C W Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 7, 2023
[A prospective clinical trial of TCD-induced regimen for symptomatic Waldenström macroglobulinemia]Y S Huang, W J Xiong, Y Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Dose-adjusted EPOCH/EDOCH plus rituximab in untreated double-protein expression lymphoma]W Liu, J Li, W Y Huang, et al.
Fa Yi Xue Za Zhi|January 24, 2020
Research Progress on Postmortem Changes of Computed Tomography Imaging Characteristics on CorpsesH W Dong, Y Sun, H Qian, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 22, 2020
[The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion]R Lyu, Y T Yan, S H Yi, et al.
Pageof 5